Skip to contentSatter Muneer A — ZETA ACQUISITION CORP II insider: 142 transactions · InsiderLensSatter Muneer A
- 10% owner at HeartWare LTD · on record since Apr 16, 2008
- Director at Annexon, Inc. · on record since May 29, 2026
- Director at Akebia Therapeutics, Inc. · on record since Mar 27, 2014
- 10% owner at Akebia Therapeutics, Inc. · on record since Mar 19, 2014
- Director at IMMUNIC, INC. · on record since Apr 23, 2014
- 10% owner at IMMUNIC, INC. · on record since Apr 23, 2014
- 10% owner at Tokai Pharmaceuticals Inc · on record since Sep 24, 2014
- 10% owner at ZETA ACQUISITION CORP II · on record since Mar 17, 2017
- Director at ZETA ACQUISITION CORP II · on record since Mar 17, 2017
- 10% owner at AMERICAN CLAIMS EVALUATION INC · on record since Jun 28, 2017
- Director at DOLLAR FINANCIAL CORP · on record since Jan 27, 2005
- Director at AMERICAN CLAIMS EVALUATION INC · on record since Jun 9, 2020
- See Remarks at AMERICAN CLAIMS EVALUATION INC · on record since Jan 8, 2021
- Director at AxonPrime Infrastructure Acquisition Corp · on record since Aug 12, 2021
- 10% owner at Annexon, Inc. · on record since Feb 14, 2023
Insider trading activity of Satter Muneer A
- Transactions on record
- 142
- since Apr 16, 2008
- Open-market buys
- 102
- $123M
- Open-market sells
- 3
- $4.1M
- Companies traded
- 7
- last filing Jun 15, 2026
Figures computed from official regulatory filings — methodology.
Companies where Satter Muneer A has traded
- Annexon, Inc.22 tx · $43.9M · Jun 15, 2026
- AMERICAN CLAIMS EVALUATION INC8 tx · $14.5M · Jan 8, 2021
- ZETA ACQUISITION CORP II35 tx · $13.8M · Jun 19, 2019
- IMMUNIC, INC.32 tx · $29.4M · Sep 17, 2018
- Akebia Therapeutics, Inc.21 tx · $20.7M · Jun 15, 2018
- Tokai Pharmaceuticals Inc6 tx · $2.3M · Sep 24, 2014
- HeartWare LTD18 tx · $2.8M · Aug 14, 2009
Track record of Satter Muneer A
Statistical track record
Free- Open-market buys
- 103
- Last buy
- May 28, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Satter Muneer A
Co-insiders of Satter Muneer A
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BIOTECHNOLOGY VALUE FUND II LPIMMUNIC, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 15, 2026 | AwardD | 65,000 | 0.00 USD | $0 | SEC |
| May 29, 2026 | Buy | 613,497 | 5.41 USD | $3.3M | SEC |
| Nov 21, 2025 | Buy | 422,613 | 4.28 USD | $1.8M | SEC |
| Nov 21, 2025 | Buy | 400,000 | 4.48 USD | $1.8M | SEC |
| Nov 19, 2025 | Buy | 500,000 | 3.94 USD | $2M | SEC |
| Nov 19, 2025 | Buy | 500,000 | 2.99 USD | $1.5M | SEC |
| Nov 19, 2025 | Buy | 500,000 | 3.18 USD | $1.6M | SEC |
| Jun 9, 2025 | AwardD | 55,000 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | AwardD | 44,000 | 0.00 USD | $0 | SEC |
| Dec 28, 2023 | Buy | 350,000 | 2.88 USD | $1M | SEC |
| Jun 12, 2023 | AwardD | 24,000 | 0.00 USD | $0 | SEC |
| Feb 14, 2023 | Buy | 2,647,058 | 6.80 USD | $18M | SEC |
| Jul 11, 2022 | BuyD | 613,497 | 0.13 USD | $79.8K | SEC |
| Jul 11, 2022 | Buy | 2,453,988 | 3.84 USD | $9.4M | SEC |
| Jun 13, 2022 | AwardD | 24,000 | 0.00 USD | $0 | SEC |
| Jun 4, 2021 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jan 8, 2021 | Buy | 9,000,000 | 1.10 USD | $9.9M | SEC |
| Jul 28, 2020 | OtherD | -4,016,573 | — | — | SEC |
| Jul 28, 2020 | Other | 1,754,978 | — | — | SEC |
| Jul 28, 2020 | Buy | 200,000 | 17.00 USD | $3.4M | SEC |
| Jul 28, 2020 | OtherD | -3,095,238 | — | — | SEC |
| Jul 28, 2020 | OtherD | -2,812,543 | — | — | SEC |
| Jul 28, 2020 | OtherD | -5,537,036 | — | — | SEC |
| Jun 9, 2020 | Buy | 3,700,000 | 1.10 USD | $4.1M | SEC |
| Jun 19, 2019 | AwardD | 21,400 | 0.00 USD | $0 | SEC |